These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37535378)

  • 1. Outcomes of Treatment With Neoadjuvant Cemiplimab for Patients With Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial.
    Ferrarotto R; Nagarajan P; Maronge JM; Johnson JM; Rosenthal DI; Myers JN; Gross ND
    JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):847-849. PubMed ID: 37535378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Ferrarotto R; Amit M; Nagarajan P; Rubin ML; Yuan Y; Bell D; El-Naggar AK; Johnson JM; Morrison WH; Rosenthal DI; Glisson BS; Johnson FM; Lu C; Mott FE; Esmaeli B; Diaz EM; Gidley PW; Goepfert RP; Lewis CM; Weber RS; Wargo JA; Basu S; Duan F; Yadav SS; Sharma P; Allison JP; Myers JN; Gross ND
    Clin Cancer Res; 2021 Aug; 27(16):4557-4565. PubMed ID: 34187851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 study.
    Gross ND; Miller DM; Khushalani NI; Divi V; Ruiz ES; Lipson EJ; Meier F; Su YB; Swiecicki PL; Atlas J; Geiger JL; Hauschild A; Choe JH; Hughes BGM; Schadendorf D; Patel VA; Homsi J; Taube JM; Lim AM; Ferrarotto R; Yoo SY; Mathias M; Han H; Seebach F; Lowy I; Fury MG; Rischin D
    Lancet Oncol; 2023 Nov; 24(11):1196-1205. PubMed ID: 37875144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
    Gross ND; Miller DM; Khushalani NI; Divi V; Ruiz ES; Lipson EJ; Meier F; Su YB; Swiecicki PL; Atlas J; Geiger JL; Hauschild A; Choe JH; Hughes BGM; Schadendorf D; Patel VA; Homsi J; Taube JM; Lim AM; Ferrarotto R; Kaufman HL; Seebach F; Lowy I; Yoo SY; Mathias M; Fenech K; Han H; Fury MG; Rischin D
    N Engl J Med; 2022 Oct; 387(17):1557-1568. PubMed ID: 36094839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Favorable efficacy of S-1 treatment for locoregionally advanced cutaneous squamous cell carcinoma in the head and neck region.
    Izumi T; Teramoto Y; Kamimura A; Doi R; Takai S; Mori T; Koizumi S; Kawahara Y; Aitake U; Lei X; Inomata N; Inafuku K; Nakamura Y
    J Dermatol; 2024 Feb; 51(2):271-279. PubMed ID: 38009848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of locoregional recurrence in cutaneous squamous cell carcinoma of the head and neck.
    Strassen U; Hofauer B; Jacobi C; Knopf A
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):501-506. PubMed ID: 27498202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemo-immunotherapy with camrelizumab plus nab-paclitaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck: a pilot phase II trial.
    Wu D; Li Y; Xu P; Fang Q; Cao F; Lin H; Li Y; Su Y; Lu L; Chen L; Li Y; Zhao Z; Hong X; Li G; Tian Y; Sun J; Yan H; Fan Y; Zhang X; Li Z; Liu X
    Nat Commun; 2024 Mar; 15(1):2177. PubMed ID: 38467604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck.
    Tam S; Gajera M; Luo X; Glisson BS; Ferrarotto R; Johnson FM; Mott FE; Gillison ML; Lu C; Le X; Blumenschein GR; Wong MK; Rosenthal DI; Nagarajan P; El-Naggar AK; Midgen MR; Weber RS; Myers JN; Gross ND
    Head Neck; 2021 May; 43(5):1592-1603. PubMed ID: 33522021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.
    Ferris RL; Spanos WC; Leidner R; Gonçalves A; Martens UM; Kyi C; Sharfman W; Chung CH; Devriese LA; Gauthier H; Chiosea SI; Vujanovic L; Taube JM; Stein JE; Li J; Li B; Chen T; Barrows A; Topalian SL
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial.
    Zhang Z; Wu B; Peng G; Xiao G; Huang J; Ding Q; Yang C; Xiong X; Ma H; Shi L; Yang J; Hong X; Wei J; Qin Y; Wan C; Zhong Y; Zhou Y; Zhao X; Leng Y; Zhang T; Wu G; Yao M; Zhang X; Yang K
    Clin Cancer Res; 2022 Aug; 28(15):3268-3276. PubMed ID: 35766967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
    Migden MR; Khushalani NI; Chang ALS; Lewis KD; Schmults CD; Hernandez-Aya L; Meier F; Schadendorf D; Guminski A; Hauschild A; Wong DJ; Daniels GA; Berking C; Jankovic V; Stankevich E; Booth J; Li S; Weinreich DM; Yancopoulos GD; Lowy I; Fury MG; Rischin D
    Lancet Oncol; 2020 Feb; 21(2):294-305. PubMed ID: 31952975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma With Adverse Events After Surgery in Treatment-Naive Patients.
    Tang AL; O'Neil T; McDermott S; Tripathi S; Tikhtman R; Mark JR; Patil Y; Tabangin M; Altaye M; Wise-Draper TM; Zender CA
    JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):935-939. PubMed ID: 36006622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of advanced cutaneous squamous cell carcinoma lesions on the head and neck successfully treated with nivolumab.
    Ishiguro A; Ogata D; Namikawa K; Takahashi A; Yamazaki N
    J Dermatol; 2021 Sep; 48(9):e434-e435. PubMed ID: 34018639
    [No Abstract]   [Full Text] [Related]  

  • 15. Commentary on "Outcomes of Sentinel Lymph Node Biopsy for Primary Cutaneous Squamous Cell Carcinoma of the Head and Neck".
    Carr DR
    Dermatol Surg; 2022 Feb; 48(2):162-163. PubMed ID: 34889210
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential chemosurgery for advanced head and neck cancer: another pathway in a complex maze?
    Robbins KT
    Ann Surg Oncol; 2003 Jul; 10(6):593-5. PubMed ID: 12839842
    [No Abstract]   [Full Text] [Related]  

  • 17. The Role of Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma.
    McMullen CP; Ow TJ
    Otolaryngol Clin North Am; 2021 Apr; 54(2):343-355. PubMed ID: 33583597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrochemotherapy for the treatment of recurrent head and neck cancers: preliminary results.
    Mevio N; Bertino G; Occhini A; Scelsi D; Tagliabue M; Mura F; Benazzo M
    Tumori; 2012; 98(3):308-13. PubMed ID: 22825505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.
    Harris BN; Bayoumi A; Rao S; Moore MG; Farwell DG; Bewley AF
    Otolaryngol Head Neck Surg; 2017 May; 156(5):863-869. PubMed ID: 28322123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma.
    Hiller A; Oxford M; Kulkarni P; Fornadley J; Lo A; Sivik J; Drabick J; Vakharia K
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S129-S131. PubMed ID: 38556660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.